Renaissance Capital logo

MYNZ News

Renaissance Capital’s November IPO Market Update

Mainz Biomed logo

During November, 34 IPOs raised $17.6 billion, the IPO market's biggest November since 1999. Blank check companies continued to gain momentum, as 60 SPACs raised $11.1 billion. The most active sector was technology, which accounted for 11 of the month's IPOs and...read more

US IPO Weekly Recap: Allbirds spreads its wings and soars 93% in a 12 IPO week

BIRD

November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting...read more

German micro-cap Mainz Biomed prices US IPO at $5 midpoint

Mainz Biomed logo

Mainz Biomed, which is commercializing in vitro molecular tests for cancer screening, raised $10 million by offering 2 million shares at $5, within the range of $4 to $6. Mainz Biomed is a molecular genetics cancer diagnostic company formed in 2021 to acquire...read more

US IPO Weekly Recap: DevOps platform GitLab leads a 7 IPO week

GTLB

The IPO market remained active this past week as seven IPOs raised $2.1 billion. SPAC activity kept steady with 10 blank check IPOs raising $1.6 billion. New filers continued to pour into the IPO pipeline, with 12 IPOs and nine SPACs submitting initial filings. ...read more